Create your own personalized MyJanssenCarePath account to:
- Learn about your insurance coverage
- Enroll in the Janssen CarePath Savings Program, if eligible
- Sign up for personal treatment reminders
Create your own personalized MyJanssenCarePath account to:
At Janssen, we don't want cost to get in the way of treatment you need. We can help you explore options to lower your out-of-pocket cost for REMICADE®. No matter what type of coverage you have – or even if you don't have coverage – Janssen CarePath can help explain your medication coverage and benefits, and help find programs that may help you pay for REMICADE®.
Summary of Resources to help you pay for REMICADE®
If you use commercial or private health insurance to pay for your medication:
Eligible patients using commercial or private insurance can save on out-of-pocket medication costs for REMICADE®. Depending on the health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. Eligible patients pay $5 for each infusion, with a $20,000 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. Program does not cover the cost to give you your infusion. See full eligibility requirements.
To determine if you are eligible for Janssen CarePath Savings Program and get a Savings card, if you don’t have one:
or
Complete and send a Patient Enrollment Form
Already enrolled? Create your online account at MyJanssenCarePath.com to manage your program benefits and submit rebate requests.
How to obtain a rebate if you have not created an online account:
Click here for rebate form. Complete, sign and return the rebate form (instructions on form), with required proof of purchase, to receive your rebate benefit.
Or call a Janssen CarePath Care Coordinator at 877-CarePath (877-227-3728) for help getting started.
If you are using a government-funded healthcare program to pay for your medication:
Janssen CarePath can provide information about independent resources that may be able to help with your out-of-pocket medication costs. Visit JanssenPrescriptionAssistance.com to learn more.
If you are enrolled in Medicare and using Medicare coverage to pay for your medication, our Medicare Resource Guide provides information on sources for cost support that may be available.
If you have no health plan coverage or no coverage for REMICADE®:
Janssen CarePath can provide information about independent resources that may be able to help with your out-of-pocket medication costs. Visit JanssenPrescriptionAssistance.com to learn more.
Call a Janssen CarePath Care Coordinator at 1-877-CarePath (877-227-3728) for more information.
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. To see if you might qualify for assistance, please contact a JJPAF program specialist at 1-800-652-6227 (9 AM to 6 PM ET) or visit the foundation website at www.JJPAF.org.
REMICADE® is a prescription medication used to treat:
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Plaque Psoriasis
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections which include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body or caused infections in certain areas (such as skin). Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking tumor necrosis factor (TNF) blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in male teenagers or young men with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
It is not known if REMICADE® is safe and effective in children under 6 years of age.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
The more common side effects of REMICADE® include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.
Please read the full Prescribing Information and Medication Guide for REMICADE® and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-53017v3